Cart summary

You have no items in your shopping cart.

DCC-2036

SKU: orb1227143

Description

DCC-2036 (Rebastinib) is a highly potent, non-ATP-competitive BCR-ABL1 inhibitor with IC50 of 0.8 and 4 nM for native ABL1 and gatekeeper mutant ABL1 T315I, respectively.

Images & Validation

Key Properties

CAS Number1020172-07-9
MW553.6
Purity>98% (HPLC)
FormulaC30H28FN7O3
TargetAbl1|FLT3|p-Abl1(native)|p-Abl1(T315I)|u-Abl1(native)

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Rebastinib [orb1305227]

    99.84%

    1020172-07-9

    553.59

    C30H28FN7O3

    25 mg, 5 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

DCC-2036 (orb1227143)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

500 mg
2 mg
$ 80.00
5 mg
$ 110.00
10 mg
$ 160.00
25 mg
$ 260.00
50 mg
$ 370.00
100 mg
$ 540.00
200 mg
$ 790.00